Mercy's Dr. Anurag Maheshwari Discusses Liver Cancer and Its Treatment
Doctors say the recurrence of liver cancer is quite common, happening sometimes as frequently as 50% within a three-year period. According to Dr. Anurag Maheshwari, who specializes in liver disease at The Center for Liver and Hepatobiliary Diseases, part of The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy, the prognosis with recurrence of liver cancer is good.
“In a lot of patients in whom their cancer began somewhere else and came to the liver, technically those patients are qualified as having Stage IV cancer. In the old days, we used to think of Stage IV cancer as a death sentence. These were people who had less than six months to live and had no hope. That is not the case anymore,” Dr. Maheshwari said.
Dr. Maheshwari added that there are many effective treatments including chemotherapy and radiation and there's lots of hope.
View Dr. Maheshwari’s interview regarding liver cancer and its treatment.
Founded in 1874 in downtown Baltimore by the Sisters of Mercy, Mercy Medical Center is a 183-licensed bed acute care university-affiliated teaching hospital. Mercy has been recognized as a top Maryland hospital by U.S. News & World Report; a Top 100 hospital for Women’s Health & Orthopedics by Healthgrades; is currently A-rated for Hospital Safety (Leapfrog Group), and is recognized by the American Nurses Credentialing Center as a Magnet Hospital. Mercy Medical Center is part of Mercy Health Services (MHS), the parent of Mercy’s primary care and specialty care physician enterprise, known as Mercy Personal Physicians, which employs more than 200 providers with locations in Baltimore, Lutherville, Overlea, Glen Burnie, Columbia and Reisterstown. For more information about Mercy, visit www.mdmercy.com, MDMercyMedia on Facebook, Twitter, or call 1-800-MD-Mercy.